In animal models with high cholesterol diet-induced atherosclerosis, the additional cholesterol absorbed from the diet is prevented by ezetimibe treatment, and thus the diet does not induce any reduction of plasma PCSK9, while in humans, the contribution of dietary cholesterol to TC is less, and thus the effect of ezetimibe is also minimal. This evidence concerns the gene PCSK9 and atherosclerosis.